Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- VMEO -20.5%, INDV -19.3%, JMIA -17.8%, INSG -14.9%, NICE -13.2%, TRUP -10.6%, BAND -9.7%, CVNA -9.5% (also files for stock offering), KVYO -9.5%, AEG -9%, ENVX -8.6%, WMT -8.5%, ACVA -8%, GRAB -7.9%, W -7.6%, CWK -7.1%, LAMR -5.9%, FRPT -5.4%, ECO -5.1%, EQX -5%, CVE -5%, BIRK -4.9%, ESAB -4.9%, BLDR -4.3%, TS -4.1% (also CFO to retire, names new CFO), INSM -3.9%, TFII -3.2%, EXAS -3.2%, IDA -3.1%, VTLE -3%, FIHL -3%, NTES -3%, CNP -2.6%, HST -2.2%, ROG -2.1%, EPAM -2%, BTG -1.9%, IMAX -1.7%, CCSI -1.7%, DINO -1.7%, PRMB -1.5%, GTX -1.4%, UPBD -1.4%, NDSN -1.3%, GSM -1.3%, TAC -1.3%, CAKE -1.1%, TPL -1.1%, OR -1%
Other news:
- KVYO -9.5% (stock offering by selling shareholders)
- IQ -8.3% (commences offering of $300 mln of its convertible senior notes due 2030)
- NB -4.9% (stock offering by selling shareholders; also discloses cybersecurity incident)
- DVAX -2.7% (responds to Deep Track and highlights value creation strategy)
- SFBS -1.4% (names new CFO)
- TECH -1.4% (launches an expanded menu of human and mouse RNAscope)
- LESL -1.3% (to be removed from S&P SmallCap 600)
- CDNA -1.1% (announces study showing AlloSeq cfDNA highly accurate in detecting rejection in organ transplant patients)
Analyst comments:
- DTE -1.4% (downgraded to Equal Weight from Overweight at Barclays)
- CE -0.5% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)